David Shapiro, CMO and EVP - Development at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 2,500 shares at $117.43 ($294K) on 2017-09-01, disclosed to the SEC on 2017-09-05.
Seasonal sale ($294k) by CMO and EVP - Development — this insider has traded ICPT in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.43 | 1,250 | $147K | 50.0% |
| 2 | $117.43 | 1,250 | $147K | 50.0% |
| Total | $117.43 avg | 2,500 | $294K | 100% |
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |